Very low frequencies of Toll-like receptor 2 supposed-2029T and 2258A (RS5743708) mutant alleles in southern Brazilian critically ill patients: would it be a lack of worldwide-accepted clinical applications of Toll-like receptor 2 variants?

• Published in: Genetic testing and molecular biomarkers Vol. 14; no. 3; p. 405
• Main Authors: Thurow, Helena Strelow, Sarturi, Cladinara Roberts, Fallavena, Paulo Roberto Vargas, Paludo, Francis Jackson de Oliveira, Picanço, Juliane Bentes, Fraga, Lucas Rosa, Graebin, Pietra, de Souza, Vinícius Carolino, Dias, Fernando Suparregui, Nóbrega, Otávio de Tolêdo, Alho, Clarice Sampaio
• Format: Journal Article
• Language: English
• Published: United States 01.06.2010
• Subjects: Adult; Aged; Alleles; Brazil; Communicable Diseases - complications; Communicable Diseases - genetics; Critical Illness; Female; Gene Frequency; Genetic Markers; Genetic Variation; Genotype; Humans; Male; Middle Aged; Mutation; Phenotype; Polymorphism, Single Nucleotide; Sepsis - etiology; Sepsis - genetics; Toll-Like Receptor 2 - genetics; Brazil
• ISSN: 1945-0257
• DOI: 10.1089/gtmb.2009.0169

Toll-like receptor 2 (TLR2) is a recognition receptor for the widest repertoire of pathogen-associated molecular patterns. Two polymorphisms of TLR2 could be linked to reduced nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) activation and to increased risk of infection (supposed-2029C>T and 2258G>A). We investigated the supposed-2029C>T and 2258G>A TLR2 polymorphisms in 422 critically ill patients of European origin from southern Brazil (295 with sepsis and 127 without sepsis) and reviewed 33 studies on these polymorphisms, conducting a quality assessment with a score system. Among our patients we found only one heterozygote (1/422) for the supposed-2029C>T and none for the 2258G>A (0/422) single nucleotide polymorphism (SNP). We were unable to find a clinical application of supposed-2029T and 2258A allele analyses in our southern Brazilian population. Our review detected that current TLR2 SNP assays had very controversial and contradictory results derived from reports with a variety of investigation quality criteria. We suggest that, if analyzed alone, the supposed-2029C>T and 2258G>A TLR2 SNP are not good candidates for genetic markers in studies that search for direct or indirect clinical applications between genotype and phenotype. Future efforts to improve the knowledge and to provide other simultaneous genetic markers might reveal a more effective TLR2 effect on the susceptibility to infectious diseases.